Medspoke | medspoke.co

Medspoke's Talks

Diabetes, Obesity and Metabolism

Published October 12, 2026

Comparative Cardiorenal Efficacy and Safety of SGLT2 Inhibitors and Finerenone in Chronic Kidney ...

October 13, 2026

Diabetes, Obesity and Metabolism

Published October 13, 2026

00:00

--:--

SGLT2 Inhibitors Reduce Heart Failure Hospitalization, Cardiovascular Death and Kidney Outcomes i...

October 13, 2026

The Lancet Haematology

Published October 11, 2026

Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia.

October 12, 2026

Why are you reporting this TALK?